[HTML][HTML] Effectiveness of COVID‑19 vaccines and their challenges
G Marfe, S Perna, AK Shukla - Experimental and …, 2021 - spandidos-publications.com
At the end of 2019, a new disease recognized such as severe acute respiratory syndrome
(SARS), was reported in Wuhan, China. This disease was caused by an unknown SARS …
(SARS), was reported in Wuhan, China. This disease was caused by an unknown SARS …
COVID-19 vaccine: where are we now and where should we go?
S Soleimanpour, A Yaghoubi - Expert review of vaccines, 2021 - Taylor & Francis
Introduction The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has
currently caused the pandemic with a high progressive speed and has been considered as …
currently caused the pandemic with a high progressive speed and has been considered as …
[HTML][HTML] The COVID-19 vaccines: recent development, challenges and prospects
Y Yan, Y Pang, Z Lyu, R Wang, X Wu, C You, H Zhao… - Vaccines, 2021 - mdpi.com
The highly infectious coronavirus disease 2019 (COVID-19) associated with the pathogenic
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to become a …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to become a …
[HTML][HTML] COVID-19 Vaccines over Three Years after the Outbreak of the COVID-19 Epidemic
AA Zasada, A Darlińska, A Wiatrzyk, K Woźnica… - Viruses, 2023 - mdpi.com
The outbreak of COVID-19 started in December 2019 and spread rapidly all over the world.
It became clear that the development of an effective vaccine was the only way to stop the …
It became clear that the development of an effective vaccine was the only way to stop the …
Host factors and vaccine efficacy: Implications for COVID‐19 vaccines
S Falahi, A Kenarkoohi - Journal of medical virology, 2022 - Wiley Online Library
The efficacy of the vaccines varies between individuals and populations. The
immunogenicity of the vaccine is influenced by various factors, including host factors …
immunogenicity of the vaccine is influenced by various factors, including host factors …
[HTML][HTML] Vaccines for COVID-19: a systematic review of immunogenicity, current development, and future prospects
Z Zhang, Q Shen, H Chang - Frontiers in immunology, 2022 - frontiersin.org
The persistent coronavirus disease 2019 (COVID-19), characterized by severe respiratory
syndrome, is caused by coronavirus 2 (SARS-CoV-2), and it poses a major threat to public …
syndrome, is caused by coronavirus 2 (SARS-CoV-2), and it poses a major threat to public …
COVID‐19 vaccines: what do we know so far?
When the novel coronavirus was described in late 2019, it could not have been imagined
that within a year, more than 100 vaccine candidates would be in preclinical development …
that within a year, more than 100 vaccine candidates would be in preclinical development …
Understanding the mechanisms for COVID-19 vaccine's protection against infection and severe disease
H Yang, Y Xie, C Li - Expert Review of Vaccines, 2023 - Taylor & Francis
Introduction Multiple COVID-19 vaccines have been approved and employed in the fight
against the pandemic. However, these vaccines have limited long-term effectiveness against …
against the pandemic. However, these vaccines have limited long-term effectiveness against …
[HTML][HTML] COVID-19 vaccines
D Ndwandwe, CS Wiysonge - Current opinion in immunology, 2021 - Elsevier
Highlights•COVID-19 vaccine development has accelerated at an incredible rate with 105
vaccines in clinical development and 18 approved for emergency use.•This is the first time in …
vaccines in clinical development and 18 approved for emergency use.•This is the first time in …
[HTML][HTML] A COVID-19 vaccine: big strides come with big challenges
J Mellet, MS Pepper - Vaccines, 2021 - mdpi.com
As of 8 January 2021, there were 86,749,940 confirmed coronavirus disease 2019 (COVID-
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …